Publication:
Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study (Clinical Drug Investigation, (2018), 38, 9, (853-865), 10.1007/s40261-018-0678-5)

Suggested Citation

Sermsiri Sangroongruangsri, Usa Chaikledkaew, Suthasinee Kumluang, Olivia Wu, Claudia Geue, Tanapat Ratanapakorn, Pattara Leelahavarong, Lily Ingsrisawang, Paisan Ruamviboonsuk, Wongsiri Taweebanjongsin, Janejit Choovuthayakorn, Apichart Singalavanija, Prut Hanutsaha, Kittisak Kulvichit, Thitiporn Ratanapojnard, Warapat Wongsawad, Yot Teerawattananon Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study (Clinical Drug Investigation, (2018), 38, 9, (853-865), 10.1007/s40261-018-0678-5). Clinical Drug Investigation. Vol.39, No.1 (2019), 115. doi:10.1007/s40261-019-00747-y Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/51947

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Availability

Collections